Challenges, one of France’s leading business and innovation media outlets, regularly features startups whose technologies have the potential to reshape key industrial and societal sectors. Its coverage focuses on companies combining scientific depth, technological differentiation, and long-term vision.
In 2023, Challenges published an article dedicated to Beams, presenting the company’s mission to improve cancer treatment through advanced detection technologies rooted in nuclear medicine and medical physics. The article highlights Beams’ ambition to bring greater precision to surgical procedures, by translating complex physical phenomena into actionable clinical information.
This publication acknowledges the multidisciplinary efforts behind the project, combining fundamental research, engineering, and close collaboration with the medical community. It also reinforces Beams’ positioning as a deeptech startup addressing a critical healthcare challenge with a strong scientific foundation.
Beyond visibility, this editorial recognition contributes to strengthening Beams’ credibility within the innovation ecosystem, supporting discussions with partners, institutions, and stakeholders interested in the future of medical and nuclear technologies.
Explore the latest advances, clinical insights, and technology shaping the future of intraoperative tumor detection. Stay informed with expert perspectives from Beams and our partners.
Back to news
Beams’ co-founder and president, Virginie Simon, was recently profiled by Les Deeptech, an initiative of Bpifrance highlighting deeptech leaders. The feature shares Virginie’s inspiring journey and the vision driving Beams as it develops innovative tools to transform intraoperative cancer care.
Read article
As part of the 10th anniversary of the 3DEXPERIENCE Lab acceleration program, Beams was invited to present its technology on BFM Business. This opportunity allowed us to share our mission, our scientific roots, and our approach to improving surgical precision through real-time intraoperative tumor detection.
Read article
In 2023, CNRS Île-de-France published an article highlighting Beams’ work on developing a new tool to improve the completeness of tumor ablations during surgery. This recognition underscores the strong scientific roots of the project and its contribution to advancing precision in surgical oncology.
Read article
In 2023, Beams was selected as a laureate of the i-Lab Innovation Competition, France’s leading national program supporting deeptech startups. This milestone recognizes the scientific maturity of the project and supports the transition from advanced research to pre-industrial medical technologies.
Read article
In 2023, Beams was selected in the Challenges magazine list of the 100 startups to invest in, a benchmark ranking highlighting the most promising French technology ventures. This recognition underscores the relevance of Beams’ scientific approach and its long-term potential in medical and nuclear technologies.
Read article
In 2023, Université Paris-Saclay published an article highlighting Beams’ work in medical technologies serving surgical oncology. This recognition emphasizes the strong scientific foundations of the project and its roots in academic research translated into clinical innovation.
Read article
In 2023, Techniques de l’Ingénieur published an article highlighting Beams’ work on real-time detection of tumor tissues during surgery. This coverage emphasizes the technological and scientific foundations of the solution, as well as its potential impact on surgical oncology.
Read article